Authors

• Eva Švehlíková (ORCID: https://orcid.org/0000-0002-9743-2031)
• Thomas Rudolf Pieber (ORCID: https://orcid.org/0000-0003-3554-0405)
• Zvonko Miličević
• Chrisanthi A. Karanikas (ORCID: https://orcid.org/0009-0008-0614-8264)
• Shweta Urva (ORCID: https://orcid.org/0000-0002-3681-479X)
• Axel Haupt (ORCID: https://orcid.org/0000-0003-4502-0470)
• Vera Höller
• Tamer Coşkun (ORCID: https://orcid.org/0000-0002-2481-133X)
• Chunmei Zhou (ORCID: https://orcid.org/0000-0003-4888-1962)
• Gabriele Fluhr
• Edward Pratt (ORCID: https://orcid.org/0000-0003-4449-6231)

Institutions

• Eli Lilly (United States) (US)
• Medical University of Graz (AT)
• Eli Lilly (Singapore) (SG)
• Clinical Nutrition Research Centre (SG)

Publication Details

Journal

Frontiers in Endocrinology

Published

2025-09-02

DOI

https://doi.org/10.3389/fendo.2025.1627947

Citations

1

Primary Topic

Diabetes Management and Research

Type

article

Field-Weighted Citation Impact

1.29

Funders

• American Diabetes Association
• Eli Lilly and Company
• European Foundation for the Study of Diabetes